SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-052314
Filing Date
2022-04-28
Accepted
2022-04-28 16:31:06
Documents
6
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223513-1_def14a.htm DEF 14A 1099951
2 GRAPHIC lg_leaptherapeu-4c.jpg GRAPHIC 57593
3 GRAPHIC sg_chrismirabelli-bwlr.jpg GRAPHIC 255035
4 GRAPHIC sg_douglaseonsi-bw.jpg GRAPHIC 10824
5 GRAPHIC tm223513d1-px_proxy1pg1bw.jpg GRAPHIC 2390491
6 GRAPHIC tm223513d1-px_proxy1pg2bw.jpg GRAPHIC 1902172
  Complete submission text file 0001104659-22-052314.txt   7456630
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37990 | Film No.: 22867186
SIC: 2834 Pharmaceutical Preparations